These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 17574789

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The selenium state of children. II. Selenium content of serum, whole blood, hair and the activity of erythrocyte glutathione peroxidase in dietetically treated patients with phenylketonuria and maple-syrup-urine disease.
    Lombeck I, Kasperek K, Harbisch HD, Becker K, Schumann E, Schröter W, Feinendegen LE, Bremer HJ.
    Eur J Pediatr; 1978 Jul 19; 128(4):213-23. PubMed ID: 668729
    [Abstract] [Full Text] [Related]

  • 3. Oxidative stress in plasma from maple syrup urine disease patients during treatment.
    Barschak AG, Sitta A, Deon M, Barden AT, Dutra-Filho CS, Wajner M, Vargas CR.
    Metab Brain Dis; 2008 Mar 19; 23(1):71-80. PubMed ID: 18026828
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selenium requirements in patients with inborn errors of amino acid metabolism and selenium deficiency.
    Lombeck I, Kasperek K, Bachmann D, Feinendegen LE, Bremer HJ.
    Eur J Pediatr; 1980 Jun 19; 134(1):65-8. PubMed ID: 7408912
    [Abstract] [Full Text] [Related]

  • 6. [Selenium and glutathione peroxidase in the blood of children].
    Zachara B.
    Pol Tyg Lek; 1980 Jun 19; 38(28-29):909-13. PubMed ID: 6419210
    [No Abstract] [Full Text] [Related]

  • 7. Effect of selenium supplementation on the distribution of selenium among plasma proteins of a patient with maple syrup urine disease.
    Borglund M, Sjöblad S, Akesson B.
    Eur J Pediatr; 1989 Aug 19; 148(8):767-9. PubMed ID: 2792131
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the mechanisms involved in leucine-induced oxidative damage in cerebral cortex of young rats.
    Bridi R, Latini A, Braum CA, Zorzi GK, Moacir W, Lissi E, Dutra-Filho CS.
    Free Radic Res; 2005 Jan 19; 39(1):71-9. PubMed ID: 15875814
    [Abstract] [Full Text] [Related]

  • 10. Preliminary results of PBA-loaded nanoparticles development and the effect on oxidative stress and neuroinflammation in rats submitted to a chemically induced chronic model of MSUD.
    Mescka CP, de Moura Coelho D, Sitta A, Catarino F, Donida B, Rosa AP, Gonzalez EA, Pinheiro CV, Poletto F, Baldo G, Dutra-Filho CS, Vargas CR.
    Metab Brain Dis; 2021 Jun 19; 36(5):1015-1027. PubMed ID: 33620579
    [Abstract] [Full Text] [Related]

  • 11. Erythrocyte antioxidant enzymes and selenium serum levels in an Andean population.
    Agostoni A, Gerli GC, Beretta L, Palazzini G, Buso GP, Hu XS, Moschini G.
    Clin Chim Acta; 1983 Sep 30; 133(2):153-7. PubMed ID: 6627681
    [Abstract] [Full Text] [Related]

  • 12. Amino acids levels and lipid peroxidation in maple syrup urine disease patients.
    Barschak AG, Sitta A, Deon M, Busanello EN, Coelho DM, Cipriani F, Dutra-Filho CS, Giugliani R, Wajner M, Vargas CR.
    Clin Biochem; 2009 Apr 30; 42(6):462-6. PubMed ID: 19121297
    [Abstract] [Full Text] [Related]

  • 13. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
    Yang N, Han LS, Ye J, Qiu WJ, Zhang HW, Gao XL, Wang Y, Li XY, Xu H, Gu XF.
    Zhonghua Yi Xue Za Zhi; 2012 Oct 30; 92(40):2839-42. PubMed ID: 23290213
    [Abstract] [Full Text] [Related]

  • 14. Early diagnosis of maple syrup urine disease using polymerase chain reaction-based mutation detection.
    Silao CL, Padilla CD, Matsuo M.
    Pediatr Int; 2008 Jun 30; 50(3):312-4. PubMed ID: 18533943
    [Abstract] [Full Text] [Related]

  • 15. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
    Funchal C, Latini A, Jacques-Silva MC, Dos Santos AQ, Buzin L, Gottfried C, Wajner M, Pessoa-Pureur R.
    Neurochem Int; 2006 Dec 30; 49(7):640-50. PubMed ID: 16822590
    [Abstract] [Full Text] [Related]

  • 16. Selenium supplementation: plasma glutathione peroxidase an indicator of selenium intake.
    Lombeck I, Menzel H, Steiner G, Kasperek K.
    Klin Padiatr; 1982 Dec 30; 194(5):303-5. PubMed ID: 7144044
    [Abstract] [Full Text] [Related]

  • 17. Plasma selenium content, platelet glutathione peroxidase and superoxide dismutase activity of residents in Kashin-Beck disease affected area in China.
    Wu J, Xu GL.
    J Trace Elem Electrolytes Health Dis; 1987 Sep 30; 1(1):39-43. PubMed ID: 2856563
    [Abstract] [Full Text] [Related]

  • 18. [Maple syrup urine disease with an intermittent relatively benign course].
    Müller H, Bickel H, Feist D, Lutz P.
    Dtsch Med Wochenschr; 1971 Oct 30; 96(40):1552-7. PubMed ID: 5093339
    [No Abstract] [Full Text] [Related]

  • 19. An early diagnosis leads to a good prognosis: a patient with maple syrup urine disease--screened by tandem mass spectrometry.
    Lin JF, Chiu PC, Hsu HY, Lin SM, Chen YY, Hsieh KS.
    Acta Paediatr Taiwan; 2004 Oct 30; 45(5):287-9. PubMed ID: 15868812
    [Abstract] [Full Text] [Related]

  • 20. Intermittent branched chain ketonuria (variant of maple syrup urine disease).
    Irwin WC, Martel SB, Goluboff N.
    Clin Biochem; 1971 Jun 30; 4(2):52-8. PubMed ID: 5128296
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.